Top Section/Ad
Top Section/Ad
Most recent
Regulators nervous about the perils of private credit should reflect on their own role restraining bank lending while pushing insurers into private markets
The Fairbridge 2025-1 transaction is a huge leap in the right direction for bringing the asset class to the public RMBS market
As thrilling as last week's Reverse Yankee-led corporate bond fest in Europe may have been, it did not confirm the market has matured to its magnificent final form
Greater competition may already be paying dividends
More articles/Ad
More articles/Ad
More articles
-
A survey of companies’ sensitivity to human rights casts big luxury goods companies like LVMH, Hermès and Prada in a bad light. Will investor pressure make them smarten up — or does their indifference suggest investors’ power is limited? -
The Schuldschein market, darling of European banks for the last few years, is likely to have a quieter year in 2018 — its first without breaking an issuance record for some time. But there is no need to worry: the product is strong and has much to offer.
-
If the principles-based European covered bond directive is implemented in its current draft form not a lot will change — but that may be just as well.
-
The confusion over UniCredit’s Cashes notes is not a one-off. Uncertainty over regulatory capital eligibility affects the biggest banks in Europe, and it is unlikely to go away soon.
-
Equity and bond investors hoping for the Turkish central bank to step in and cool its overheating economy will be dismayed by President Erdogan’s pledge to influence its decisions. But they should not be surprised.
-
Chinese technology company ZTE Corp appears to have been saved from the brink, after US President Donald Trump’s surprising intervention on Twitter. But although that may look like good news to ZTE’s investors, it should not be applauded by anyone else. The only thing predictable about the trade war between China and the US is quite how unpredictable it will be.
